<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font17 { font-size : 17; } .font23 { font-size : 23; } .font10 { font-size : 10; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font30 { font-size : 30; } .font14 { font-size : 14; } .font15 { font-size : 15; }</style>
 <body>
  <p>
   <span class="font30">the </span>
   <span class="font23">and </span>
   <span class="font17">for </span>
   <span class="font15">product </span>
   <span class="font14">clinical </span>
   <span class="font14">would </span>
   <span class="font14">The </span>
   <span class="font14">could </span>
   <span class="font13">production </span>
   <span class="font13">cell </span>
   <span class="font13">development </span>
   <span class="font13">drug </span>
   <span class="font13">from </span>
   <span class="font12">process </span>
   <span class="font12">{background </span>
   <span class="font12">mAb </span>
   <span class="font12">that </span>
   <span class="font12">with </span>
   <span class="font12">are </span>
   <span class="font12">phase </span>
   <span class="font12">â€" </span>
   <span class="font12">margin </span>
   <span class="font12">may </span>
   <span class="font12">this </span>
   <span class="font11">cGMP </span>
   <span class="font11">pandemic </span>
   <span class="font11">{border-style </span>
   <span class="font11">manufacturing </span>
   <span class="font11">not </span>
   <span class="font11">px;} </span>
   <span class="font11">risk </span>
   <span class="font11">#ffffff;} </span>
   <span class="font11">have </span>
   <span class="font11">time </span>
   <span class="font11">timeline </span>
   <span class="font11">enable </span>
   <span class="font11">rapid </span>
   <span class="font11">studies </span>
   <span class="font11">also </span>
   <span class="font11">identification </span>
   <span class="font11">material </span>
   <span class="font11">capacity </span>
   <span class="font11">companies </span>
   <span class="font11">IND </span>
   <span class="font11">been </span>
   <span class="font11">but </span>
   <span class="font11">established </span>
   <span class="font11">line </span>
   <span class="font11">mAbs </span>
   <span class="font11">months </span>
   <span class="font11">more </span>
   <span class="font11">path </span>
   <span class="font11">platform </span>
   <span class="font11">substance </span>
   <span class="font10">This </span>
   <span class="font10">fastest </span>
   <span class="font10">lead </span>
   <span class="font10">new </span>
   <span class="font10">safety </span>
   <span class="font10">testing </span>
   <span class="font10">IgG </span>
   <span class="font10">bank </span>
   <span class="font10">critical </span>
   <span class="font10">quality </span>
   <span class="font10">single </span>
   <span class="font10">such </span>
   <span class="font10">therapeutic </span>
   <span class="font10">toxicology </span>
   <span class="font10">For </span>
   <span class="font10">Prog../btpr. </span>
   <span class="font10">bioreactors </span>
   <span class="font10">can </span>
   <span class="font10">commercial </span>
   <span class="font10">evaluation </span>
   <span class="font10">has </span>
   <span class="font10">including </span>
   <span class="font10">many </span>
   <span class="font10">one </span>
   <span class="font10">px; </span>
   <span class="font10">regulatory </span>
   <span class="font10">should </span>
   <span class="font10">these </span>
   <span class="font10">using </span>
   <span class="font10">without </span>
   <span class="font10">{font-family </span>
   <span class="font10">al.Biotechnol. </span>
   <span class="font10">any </span>
   <span class="font10">approaches </span>
   <span class="font10">business </span>
   <span class="font10">combination </span>
   <span class="font10">current </span>
   <span class="font10">described </span>
   <span class="font10">discovery </span>
   <span class="font10">font-size </span>
   <span class="font10">into </span>
   <span class="font10">large </span>
   <span class="font10">lines </span>
   <span class="font10">other </span>
   <span class="font10">outbreak </span>
   <span class="font10">reduce </span>
   <span class="font10">several </span>
   <span class="font10">strategies </span>
   <span class="font10">subsequent </span>
   <span class="font10">supply </span>
   <span class="font10">use </span>
   <span class="font10">was </span>
   <span class="font10">These </span>
   <span class="font10">between </span>
   <span class="font10">culture </span>
   <span class="font10">doses </span>
   <span class="font10">double; </span>
   <span class="font10">early </span>
   <span class="font10">first </span>
   <span class="font10">initial </span>
   <span class="font10">master </span>
   <span class="font10">months. </span>
   <span class="font10">need </span>
   <span class="font10">pools </span>
   <span class="font10">production. </span>
   <span class="font10">savings </span>
   <span class="font10">screening </span>
   <span class="font10">speed </span>
   <span class="font10">stability </span>
   <span class="font10">strategy </span>
   <span class="font10">studies. </span>
   <span class="font10">than </span>
   <span class="font10">there </span>
   <span class="font10">trials. </span>
   <span class="font10">(). </span>
   <span class="font10">CMC </span>
   <span class="font10">accelerated </span>
   <span class="font10">antibodies </span>
   <span class="font10">before </span>
   <span class="font10">biopharmaceutical </span>
   <span class="font10">border-color </span>
   <span class="font10">border-width </span>
   <span class="font10">clones </span>
   <span class="font10">cloning </span>
   <span class="font10">disease </span>
   <span class="font10">downstream </span>
   <span class="font10">enables </span>
   <span class="font10">final </span>
   <span class="font10">formulation </span>
   <span class="font10">integration </span>
   <span class="font10">little </span>
   <span class="font10">low </span>
   <span class="font10">major </span>
   <span class="font10">patient </span>
   <span class="font10">performance </span>
   <span class="font10">produce </span>
   <span class="font10">profile </span>
   <span class="font10">provide </span>
   <span class="font10">release </span>
   <span class="font10">single-use </span>
   <span class="font10">solid; </span>
   <span class="font10">stages </span>
   <span class="font10">trial </span>
   <span class="font10">used </span>
   <span class="font10">viral </span>
   <span class="font10">well </span>
   <span class="font10">which </span>
   <span class="font10">years </span>
   <span class="font10">{font-style </span>
   <span class="font10">{font-weight </span>
   <span class="font10">(for </span>
   <span class="font10">,â€", </span>
   <span class="font10">Although </span>
   <span class="font10">Another </span>
   <span class="font10">Using </span>
   <span class="font10">accelerate </span>
   <span class="font10">acceleration </span>
   <span class="font10">all </span>
   <span class="font10">analysis </span>
   <span class="font10">assessing </span>
   <span class="font10">batch </span>
   <span class="font10">batches </span>
   <span class="font10">bold </span>
   <span class="font10">clinic </span>
   <span class="font10">conventional </span>
   <span class="font10">courier; </span>
   <span class="font10">cultures </span>
   <span class="font10">derived </span>
   <span class="font10">directly </span>
   <span class="font10">during </span>
   <span class="font10">em; </span>
   <span class="font10">enabling </span>
   <span class="font10">facility </span>
   <span class="font10">few </span>
   <span class="font10">highly </span>
   <span class="font10">innovator </span>
   <span class="font10">launch </span>
   <span class="font10">licensure </span>
   <span class="font10">likely </span>
   <span class="font10">materials </span>
   <span class="font10">monoclonal </span>
   <span class="font10">multiple </span>
   <span class="font10">outbreak, </span>
   <span class="font10">per </span>
   <span class="font10">pilot </span>
   <span class="font10">pool </span>
   <span class="font10">potentially </span>
   <span class="font10">practice </span>
   <span class="font10">product. </span>
   <span class="font10">production, </span>
   <span class="font10">productivity </span>
   <span class="font10">pt;} </span>
   <span class="font10">recent </span>
   <span class="font10">required </span>
   <span class="font10">risks </span>
   <span class="font10">same </span>
   <span class="font10">save </span>
   <span class="font10">some </span>
   <span class="font10">standard </span>
   <span class="font10">steps </span>
   <span class="font10">storage </span>
   <span class="font10">sufficient </span>
   <span class="font10">suitable </span>
   <span class="font10">support </span>
   <span class="font10">technologies </span>
   <span class="font10">technology </span>
   <span class="font10">thousands </span>
   <span class="font10">through </span>
   <span class="font10">timelines </span>
   <span class="font10">trials </span>
   <span class="font10">typical </span>
  </p>
 </body>
</html>
